Epizyme (EPZM) Reports Q1 Loss of $0.39/Share

Epizyme (NASDAQ: EPZM) reported Q1 EPS of ($0.39), versus ($0.49) reported last year. Revenue for the quarter came in at $26.9 million, versus $25.6 million reported last year.

Financial Guidance

Following its March financing, and based on its current operating plan, Epizyme expects its cash runway to extend into at least the first quarter of 2021.

The company will not hold a conference call in conjunction with these results.

For earnings history and earnings-related data on Epizyme (EPZM) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c